Butterfly network

SHAREHOLDER ALERT: Morris Kandinov Investigating BFLY, FOX, and DESAX; Shareholders are Encouraged to Contact the Firm

Retrieved on: 
Mercredi, janvier 25, 2023
NYSE, Fox Corporation, DWS, Butterfly network, SAN, Advertising, Security (finance), Bank

SAN DIEGO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating Butterfly Network, Inc., Fox Corporation, and DWS ESG Core Equity Fund.

Key Points: 
  • SAN DIEGO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating Butterfly Network, Inc., Fox Corporation, and DWS ESG Core Equity Fund.
  • Morris Kandinov is investigating Butterfly Network, Inc. regarding possible breaches of fiduciary duties and other violations of law, including securities claims on behalf of shareholders.
  • Morris Kandinov is investigating Fox Corporation regarding possible breaches of fiduciary duties and other violations of law, including securities claims on behalf of shareholders.
  • Concerned shareholders are encouraged to contact Leo Kandinov to learn more:
    Morris Kandinov LLP is a national law firm that specializes in recovering investment losses and protecting stockholder rights.

Butterfly Network Completes Successful Deployment of 500 Butterfly iQ+ Devices and Training of 500+ Healthcare Workers Across 224 Facilities in Kenya

Retrieved on: 
Lundi, décembre 19, 2022
Technology, Mobile, Wireless, Health, Consumer, Practice Management, Medical Devices, Software, Managed Care, General Health, Health Technology, Hardware, Women, Semiconductor, Nursing, Mortality, Security (finance), Exhibition, Patient, Humanitarian use licenses, Annual report, NYSE, Learning, Bill & Melinda Gates Foundation, Tablet, Partnership, Omicron, Growth, COVID-19, Marketing, Butterfly network, Pregnancy, Safety, Global Health, Bill, GUSI, Multimedia, Breech, Network, Medical imaging, Pharmaceutical industry, Butterfly

View the full release here: https://www.businesswire.com/news/home/20221219005090/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221219005090/en/
    The 10 cohorts, comprising 514 practitioners in total, who have completed training and now have the skills and equipment to bring Butterfly iQ+ back to across Kenya.
  • (Photo: Business Wire)
    The first-of-its-kind program in Kenya, previously announced and launched in September 2022, represents an important step toward improving worldwide access to essential medical imaging.
  • All of the distributed Butterfly devices and tablets were pre-loaded with educational material to provide continued learning and advancement content at no cost.
  • “At Butterfly, we are on a mission to transform care through easy-to-use, portable and versatile ultrasound technology to benefit all patients worldwide.

Butterfly Network to Present at the 41st Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Mercredi, décembre 14, 2022
Health, Technology, Other Health, Software, General Health, Hardware, Butterfly network, United Kingdom, Network, Event, Conference, NYSE, Butterfly, Medical imaging

Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will participate in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California on January 9-12, 2023.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will participate in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California on January 9-12, 2023.
  • A live webcast of the presentation and an archived recording will be available in the Events & Presentations section of the Butterfly Network investor website.
  • Through its proprietary Ultrasound-on-Chip technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world.
  • Butterfly iQ+ is a prescription device intended for trained healthcare professionals only.

Butterfly Announces CEO Transition

Retrieved on: 
Mardi, décembre 6, 2022
General Health, Medical Devices, Other Health, Health, Radiology, Interim, United Kingdom, Network, Butterfly network, NYSE, Management, Butterfly

Dr. Fruchterman will partner with Butterflys leadership team through the end of the year to ensure a smooth transition.

Key Points: 
  • Dr. Fruchterman will partner with Butterflys leadership team through the end of the year to ensure a smooth transition.
  • On behalf of the Board I want to thank Todd for his vision, passion and dedication to Butterfly during his tenure, said Jonathan Rothberg, Founder and Chairman of the Board.
  • Dr. Rothberg will serve as Interim CEO during this time of transition and will work closely with Butterflys executive team to continue to drive the Company forward and ensure business continuity during the search for a permanent replacement.
  • Through its proprietary Ultrasound-on-Chip technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world.

Lifshitz Law PLLC Announces Investigations of Natera, Inc. (NASDAQ: NTRA), Butterfly Network, Inc. (NYSE: BFLY), Pulse Biosciences, Inc. (NASDAQ: PLSE), and SunPower Corporation (NASDAQ: SPWR)

Retrieved on: 
Dimanche, novembre 20, 2022
COVID-19, SunPower, Telephone, Risk, Butterfly network, Fatigue, Hewlett, Defendant, Sebaceous hyperplasia, Oportunidades, Advertising, FDA, Pharmaceutical industry, Mail, Risk management, Natera

NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) --

Key Points: 
  • If you are a Natera investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are a Butterfly Network investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are a SunPower investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.

Author Mary Longley Launches "Butterfly Network USA"

Retrieved on: 
Mercredi, novembre 2, 2022
Fire, Face, Life, Blog, Color, Family, Flower, Bullfrogs and Butterflies II, Love, Butterfly network, Housing, Friends, Woman, Deception, African diaspora, Publishing, Social justice, Book, Entertainment, Public relations, Hunting, Butterfly, Cult

Harlem, New York--(Newsfile Corp. - November 1, 2022) - African American author, Mary Longley, released her debut novel, Butterflies on October 13th, 2022.

Key Points: 
  • Harlem, New York--(Newsfile Corp. - November 1, 2022) - African American author, Mary Longley, released her debut novel, Butterflies on October 13th, 2022.
  • The goal of Butterfly Network USA is to build partnerships with communities and social justice organizations, in order to assist those in need.
  • "I write with hopes of improving the human condition," Longley explains, "and I want my business to represent that as well."
  • Longley continues to partner with local community resources to highlight their stories through Butterfly Network USA.

Butterfly Network, Inc. to Report Third Quarter 2022 Financial Results on November 3, 2022

Retrieved on: 
Lundi, octobre 24, 2022
Technology, Health, Semiconductor, Medical Devices, New, Telephone, Webcast, Network, NYSE, Technology, Butterfly network, United Kingdom, Butterfly, Mobile phone, Medical imaging

Butterfly Network, Inc. (NYSE: BFLY) (Butterfly), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report third quarter 2022 financial results and provide a business update on November 3, 2022, before the market opens.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) (Butterfly), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report third quarter 2022 financial results and provide a business update on November 3, 2022, before the market opens.
  • Dr. Todd Fruchterman, President and Chief Executive Officer, and Heather Getz, Executive Vice-President and Chief Financial Officer, will host a conference call and webcast at 8:30 am ET on November 3, 2022, to discuss third quarter 2022 financial results and operational progress.
  • Through its proprietary Ultrasound-on-Chip technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world.
  • Butterfly iQ+ is a prescription device intended for qualified healthcare professionals only.

Hyperfine Names Maria Sainz President and Chief Executive Officer

Retrieved on: 
Jeudi, octobre 6, 2022
Adoption, High-dependency unit, U.S. Securities and Exchange Commission, ICU, Therapy, Technology, Audit committee, Growth, Paola Lattus, Humanitarian use licenses, Magnetic resonance imaging, Butterfly network, Intelligence, Patient, Hospital, Income, Security (finance), MRI, Partnership, Private Securities Litigation Reform Act, Marketing, Industry, AI, Board, The Cooper Companies, CEO, Health, National Medal, GLOBE, Jonathan Rothberg, DNA, National Medal of Technology and Innovation, Clarify Op3nvoice, FDA, COVID-19, List of life sciences, Stryker, Management, Risk management, Swoop, Nasdaq, Hyperfine structure

GUILFORD, Conn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), (Hyperfine or the Company), the groundbreaking medical device company that created Swoop, the world's first FDA-cleared portable MRI system, today announced that it has named medical device industry veteran Maria Sainz as President and Chief Executive Officer (CEO) of Hyperfine, effective October 24, 2022.

Key Points: 
  • GUILFORD, Conn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), (Hyperfine or the Company), the groundbreaking medical device company that created Swoop, the world's first FDA-cleared portable MRI system, today announced that it has named medical device industry veteran Maria Sainz as President and Chief Executive Officer (CEO) of Hyperfine, effective October 24, 2022.
  • Scott Huennekens, who currently serves as interim President and CEO, will stay on as Executive Chairperson of the Board.
  • As President and CEO of Hyperfine, Ms. Sainz will lead the commercial expansion of Hyperfines Swoop portable MRI system to execute the companys mission of lowering barriers to medical imaging around the world.
  • We are very pleased to name Ms. Sainz President and CEO of Hyperfine.

Butterfly Network Launches Proficiency Management Solution at American College of Emergency Physicians Scientific Assembly 2022

Retrieved on: 
Jeudi, septembre 29, 2022
Surgery, Baby, Maternity, Other Health, Public Policy, Government, Radiology, Software, Oncology, Hardware, Medical Devices, Healthcare Reform, Hospitals, Technology, Clinical Trials, Cardiology, Women, Practice Management, Seniors, Veterinary, Physical Therapy, Nursing, Managed Care, Pets, Medical Supplies, General Health, FDA, Health, Consumer, Temple Health, Adoption, Credentialing, COVID-19, NYSE, Feedback, Company, Booth, Health, Growth, Assessment, Learning, POCUS, Partnership, U.S. Securities and Exchange Commission, Biplane, Patient, Emergency medicine, Technology, FAST, Humanitarian use licenses, Annual report, Omicron, Private Securities Litigation Reform Act, Diagnosis, Butterfly network, Security (finance), Medicine, Butterfly, Marketing, Education, Network, Medical imaging, Surgery, Baby, Maternity, Other Health, Public Policy, Government, Radiology, Software, Oncology, Hardware, Medical Devices, Healthcare Reform, Hospitals, Technology, Clinical Trials, Cardiology, Women, Practice Management, Seniors, Veterinary, Physical Therapy, Nursing, Managed Care, Pets, Medical Supplies, General Health, FDA, Health, Consumer

Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care through the power of handheld, whole-body ultrasound and connected medicine, today announced a new Proficiency Management Solution offered as part of its enterprise imaging platform, Butterfly Blueprint.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care through the power of handheld, whole-body ultrasound and connected medicine, today announced a new Proficiency Management Solution offered as part of its enterprise imaging platform, Butterfly Blueprint.
  • The Butterfly Proficiency Management System addresses much of this and will foster adoption more broadly across Emergency Medicine and many other specialties.
  • Butterflys Proficiency Management Solution automates the management and analysis of ultrasound across an institution.
  • For more information on engaging with Butterfly at ACEP22 or for information on Butterfly educational sessions and hands-on experiences, visit here .

Butterfly Network Distributes 500 Butterfly iQ+ Devices to Healthcare Workers in Kenya to Transform Maternal and Fetal Health

Retrieved on: 
Mardi, septembre 20, 2022
Women, Radiology, Baby, Maternity, Software, Medical Devices, Hardware, Hospitals, Consumer, Technology, Practice Management, Public Policy, Government, Managed Care, General Health, FDA, Health, Healthcare Reform, Training, Education, Partner, Health, COVID-19, Woman, NYSE, Risk, Entrepreneurship, Privacy, Mother, Company, World, Growth, Partnership, Bill, U.S. Securities and Exchange Commission, Pregnancy, Patient, CEO, United Kingdom, Technology, Kenyatta University, Humanitarian use licenses, Annual report, Friends, Omicron, Jomo Kenyatta, Private Securities Litigation Reform Act, Butterfly network, Death, IPad, New, Bill & Melinda Gates Foundation, Security (finance), Medicine, Marketing, Multimedia, Network, Medical imaging, Jamf, Butterfly

View the full release here: https://www.businesswire.com/news/home/20220920005351/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220920005351/en/
    The deployment of 500 Butterfly iQ+ devices, the worlds only handheld, whole-body ultrasound probe, to healthcare practitioners in Kenya to advance maternal and fetal health.
  • With Butterfly, we are changing that, said Darius Shahida, Chief Strategy Officer and Chief Business Development Officer, Butterfly Network.
  • Kenyatta University is honoured to partner with Global Ultrasound Institute and Butterfly Network in this momentous occasion.
  • Expanding access to medical imaging technology in Kenya is critical to maternal and fetal health.